Inhibrx Biosciences, Inc. INBX

99.61 (0.79) (0.79%) as of 25 Sep
Market cap
$1.5B
P/E
0.0×
Insider Buys alert about insiders buying in the last 12 month

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Older periods Sep '25 Dec '25 Mar '26 Jun '26
Cash and Short Term Investments

+8 more quarters

153.09 124.22 161.66 133.34
Receivables
0.84 0.18 0.19 0.13
Total current assets
161.42 132.83 171.34 142.21
Property, Plant, Equpment (Net)
4.31 3.73 3.20 2.69
Long-term assets (Other)
5.74 4.38 4.38 4.77
Total non-current assets
16.05 13.65 12.63 12.01
Total Assets
177.47 146.48 183.97 154.22
Accounts Payable
6.77 5.94 8.76 9.80
Accrued Expenses
26.96 25.53 15.34 15.77
Total current liabilities
35.98 33.80 26.51 28.06
Long Term Debt (Total)
99.92 100.56 174.99 176.29
Total non-current liabilities
104.66 104.69 178.49 179.14
Total liabilities
140.64 138.49 205.00 207.20
Additional Paid In Capital
250.18 254.18 258.59 263.30
Common Stock (Net)
0.00 0.00 0.00 0.00
Retained Earnings
(213.35) (246.19) (279.63) (316.28)
Common Equity (Total)
36.83 7.99 (21.03) (52.98)
Shareholders Equity (Total)
36.83 7.99 (21.03) (52.98)
Shareholders Equity and Liabilities (Total)
177.47 146.48 183.97 154.22
Shares (Common)
14.50 14.58 14.61 14.71
Shareholders Equity (Tangible)
36.83 7.99 (21.03) (52.98)
Net Debt
(53.17) (23.66) 13.34 42.94
Total Debt
99.92 100.56 174.99 176.29

Fold the line items

In millions of $ except per-share values · columns are period end dates